[Effects of irinotecan and 5-FU combination therapy in gastric cancer--is combination therapy synergic?].

Yamada, Takeshi; Furukawa, Kiyonori; Yokoi, Kimiyoshi; Mamada, Yasuhiro; Kanazawa, Yoshikazu; Uchida, Eiji

Yamada, Takeshi; Furukawa, Kiyonori; Yokoi, Kimiyoshi; Mamada, Yasuhiro; Kanazawa, Yoshikazu; Uchida, Eiji.

Affiliation

Yamada T; Dept. of Surgery, Nippon Medical School, Chiba-hokusoh Hospital.

Gan To Kagaku Ryoho ; 37(11): 2125-9, 2010 Nov.

Article in Ja | MEDLINE | ID: mdl-21084811

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Stomach Neoplasms/drug therapy; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic/administration & dosage; Antineoplastic Agents, Phytogenic/administration & dosage; Camptothecin/administration & dosage; Camptothecin/analogs & derivatives; Drug Antagonism; Drug Synergism; Female; Fluorouracil/administration & dosage; Humans; In Vitro Techniques; Irinotecan; Male; Middle Aged

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Antineoplastic Combined Chemotherapy Protocols Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: Ja Journal: Gan To Kagaku Ryoho Year: 2010 Document type: Article

Search on Google

XML

PubMed Links